https://orcid.org/0000-0002-7589-3849
References
- Fucharoen S, Winichagoon P. Haemoglobinopathies in southeast Asia. Indian J Med Res. 2011;134:498–506.
- Fucharoen S, Fucharoen G. Hb H disease with various β hemoglobinopathies: molecular, hematological and diagnostic aspects. Hemoglobin. 2012;36(1):18–24.
- Brown WJ, Niazi GA, Jayalakshmi M, et al. Hemoglobin Athens-Georgia, or alpha 2 beta 2 40(C6)Arg replaced by Lys, a hemoglobin variant with an increased oxygen affinity. Biochim Biophys Acta. 1976;439(1):70–76.
- Mrad A, Kister J, Feo C, et al. Hemoglobin Athens-Georgia [alpha 2 beta 2 40(C6)Arg-Lys] in association with beta 0-thalassemia in Tunisia. Am J Hematol. 1989;32(2):117–122.
- Blanke S, Johnsen A, Wimberley PD. Hb Athens-Georgia [beta 40(C6)Arg--Lys] in a Danish family. Hemoglobin. 1989;13(2):181–183.
- Nybo J, Hansen AT, Petersen JB, et al. Hemoglobin variants found in relation to HbA1c testing: high occurrence of Hb Athens-Georgia in the Northern Jutland, Denmark. Clin Chem Lab Med. 2019;57(6):e108–e110.
- Peeters B, Brandt I, Desmet K, et al. Hb Melusine and Hb Athens-Georgia: potentially underreported in the Belgian population? Four cases demonstrating the lack of detection using common CE-HPLC methods either for glycated hemoglobin (HbA1C) analysis or Hb variant screening. Acta Clin Belg. 2016;71(6):458–461.
- Wils J, Caneiro P, Lebourg L, et al. Fortuitous detection of a case of unknown haemoglobin Athens-Georgia from atypical HbA1c electropherogram. Clin Chim Acta. 2015;440:6–7.
- Granouillet R, Atieh S, Francina A, et al. Unexpected occurrence of hemoglobin Athens-Georgia. Ann Biol Clin (Paris). 2004;62(5):595–596.
- Srivorakun H, Singha K, Fucharoen G, et al. A large cohort of hemoglobin variants in Thailand: molecular epidemiological study and diagnostic consideration. PLoS One. 2014;9(9):e108365.
- Panyasai S, Fucharoen G, Fucharoen S. Hemoglobin variants in Northern Thailand: prevalence, heterogeneity and molecular characteristics. Genet Test Mol Biomarkers. 2016;20(1):37–43.
- Srivorakun H, Fucharoen G, Changtrakul Y, et al. Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic assessment using capillary electrophoresis system. Clin Biochem. 2011;44(5-6):406–411.
- Fucharoen S, Fucharoen G, Sriroongrueng W, et al. Molecular basis of beta-thalassemia in Thailand: analysis of beta-thalassemia mutations using the polymerase chain reaction. Hum Genet. 1989;84(1):41–46.
- Sae-Ung N, Fucharoen G, Sanchaisuriya K, et al. Alpha(0)-thalassemia and related disorders in northeast Thailand: a molecular and hematological characterization . Acta Haematol. 2007;117(2):78–82.
- Ruengdit C, Panyasai S, Kunyanone N, et al. Characterization and identification of Hb Bart's hydrops fetalis caused by a compound heterozygous mutation -SEA/-CR , a novel α0 -thalassemia deletion. Int J Lab Hematol. 2020;42(3):e116–e120.
- Chaibunruang A, Karnpean R, Fucharoen G, et al. Genetic heterogeneity of hemoglobin AEBart's disease: a large cohort data from a single referral center in northeast Thailand. Blood Cells Mol Dis. 2014;52(4):176–180.
- Fucharoen S, Sanchaisuriya K, Fucharoen G, et al. Interaction of hemoglobin E and several forms of alpha-thalassemia in Cambodian families. Haematologica. 2003;88(10):1092–1098.
- Sirichotiyakul S, Saetung R, Sanguansermsri T. Analysis of beta-thalassemia mutations in northern Thailand using an automated fluorescence DNA sequencing technique. Hemoglobin. 2003;27(2):89–95.
- Fucharoen G, Fucharoen S, Sanchaisuriya K, et al. Frequency distribution and haplotypic heterogeneity of beta(E)-globin gene among eight minority groups of northeast Thailand. Hum Hered. 2002;53(1):18–22.
- Fucharoen S, Shimizu K, Fukumaki Y. A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. Nucleic Acids Res. 1990;18(17):5245–5253.
- Epstein CJ. Non-randomness of amino-acid changes in the evolution of homologous proteins. Nature. 1967;215(5099):355–359.
- Adirojnanon P, Wasi P. Levels of haemoglobin H and proportions of red cells with inclusion bodies in the two types of haemoglobin H disease. Br J Haematol. 1980;46(3):507–509.
- Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematol Am Soc Hematol Educ Program. 2009;2009(1):26–34.
- Huang K, Ge S, Yi W, et al. Interactions of unstable hemoglobin Rush with thalassemia and hemoglobin E result in thalassemia intermedia. Hematology. 2019;24(1):459–466.